LAKE FOREST, Calif., US: On 18 June, the American dental laser manufacturer BIOLASE announced its delisting from the Nasdaq Stock Market, a move which took effect on 20 June. The regulatory action resulted from the company’s failure to meet two important criteria for listing on the exchange: a minimum bid price of US$1 per share and a minimum of US$2.5 million of stockholders’ equity.